Associations between TCA cycle plasma metabolites and fatigue in black females with systemic lupus erythematosus: An untargeted metabolomics pilot study
Restricted accessResearch articleFirst published online August, 2024
Associations between TCA cycle plasma metabolites and fatigue in black females with systemic lupus erythematosus: An untargeted metabolomics pilot study
In this pilot study, we used untargeted metabolomics to identify biochemical mechanisms or biomarkers potentially underlying SLE-related fatigue.
Methods
Metabolon conducted untargeted metabolomic plasma profiling using ultrahigh performance liquid chromatography/tandem mass spectrometry on plasma samples of 23 Black females with systemic lupus erythematosus (SLE) and 21 no SLE controls. Fatigue phenotypes of general fatigue, physical fatigue, mental fatigue, reduced activity, and reduced motivation were measured with the reliable and valid Multidimensional Fatigue Inventory (MFI).
Results
A total of 290 metabolites were significantly different between the SLE and no SLE groups, encompassing metabolites related to glycolysis, TCA cycle activity, heme catabolism, branched chain amino acids, fatty acid metabolism, and steroids. Within the SLE group, controlling for age and co-morbidities, TCA cycle metabolites of alpha-ketoglutarate (AKG) and succinate were statistically significantly associated (p < .05) with physical and general fatigue.
Conclusion
While pervasive perturbations in the entire TCA cycle have been implicated as a potential mechanism for fatigue, our results suggest individual metabolites of AKG and succinate may be potential biomarkers or targets of intervention for fatigue symptom management in SLE. Additionally, perturbations in heme metabolism in the SLE group provide additional insights into mechanisms that promote systemic inflammation.
LimSSDrenkardC. Epidemiology of lupus: an update. Curr Opin Rheumatol2015; 27(5): 427–432.
2.
ZielinskiMRSystromDMRoseNR. Fatigue, Sleep, and autoimmune and related disorders. Front Immunol2019; 10: 1827.
3.
FonsecaRBernardesMTerrosoG, et al.Silent Burdens in disease: fatigue and depression in SLE. Autoimmune Dis2014; 2014: 790724.
4.
TenchCMMcCurdieIWhitePD, et al.The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology2000; 39(11): 1249–1254.
5.
OvermanCLKoolMBDa SilvaJA, et al.The prevalence of severe fatigue in rheumatic diseases: an international study. Clin Rheumatol2016; 35(2): 409–415.
6.
DimaACaraiolaSDelceaC, et al.Self-reported disease severity in women with systemic lupus erythematosus. Rheumatol Int2019; 39(3): 533–539.
7.
SutantoBSingh-GrewalDMcNeilHP, et al.Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care Res2013; 65(11): 1752–1765.
8.
GolderVOoiJJYAntonyAS, et al.Discordance of patient and physician health status concerns in systemic lupus erythematosus. Lupus2018; 27(3): 501–506.
9.
BoothSPriceEWalkerE. Fluctuation, invisibility, fatigue - the barriers to maintaining employment with systemic lupus erythematosus: results of an online survey. Lupus2018; 27(14): 2284–2291.
10.
GordonCIsenbergDLerstromK, et al.The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey. Rheumatology2013; 52(12): 2292–2301.
11.
TaniCElefanteESignoriniV, et al.Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience. RMD Open2019; 5(2): e000916.
12.
SchneiderM. Guidelines for the management of systemic lupus erythematosus: great synthesis of evidence and eminence with limited focus on patient's needs. Rheumatology2018; 57(1): 12–13.
13.
MackayM. Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus. Immunol Res2015; 63(1-3): 26–37.
14.
JohnsonCHIvanisevicJSiuzdakG. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol2016; 17(7): 451–459.
15.
AringerMCostenbaderKDaikhD, et al.European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151-1159.
16.
KrumsiekJMittelstrassKDoKT, et al.Gender-specific pathway differences in the human serum metabolome. Metabolomics2015; 11(6): 1815–1833.
17.
CharlsonMEPompeiPAlesKL, et al.A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis1987; 40(5): 373–383.
18.
CastrejonITaniCJollyM, et al.Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care. Clin Exp Rheumatol2014; 32(5 Suppl 85): 85–95.
19.
SmetsEMGarssenBBonkeB, et al.The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res1995; 39(3): 315–325.
20.
EvansAMDeHavenCDBarrettT, et al.Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem2009; 81(16): 6656–6667.
21.
PangZChongJZhouG, et al.MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res2021; 49(W1): W388–W396.
22.
WuTXieCHanJ, et al.Metabolic disturbances associated with systemic lupus erythematosus. PLoS One2012; 7(6): e37210.
23.
ZhangTMohanC. Caution in studying and interpreting the lupus metabolome. Arthritis Res Ther2020; 22(1): 172.
24.
NelsonDCoxMM. Lehninger principles of biochemistry. New York, NY: W. H. Freeman Macmillan Learning, 2017.
25.
HuiSGhergurovichJMMorscherRJ, et al.Glucose feeds the TCA cycle via circulating lactate. Nature2017; 551(7678): 115–118.
26.
CalderPC. Functional roles of fatty acids and their effects on human health. JPEN J Parenter Enteral Nutr2015; 39(1 Suppl): 18S–32S.
27.
ShinTHKimHAJungJY, et al.Analysis of the free fatty acid metabolome in the plasma of patients with systemic lupus erythematosus and fever. Metabolomics2017; 14(1): 14.
28.
WellenKEHatzivassiliouGSachdevaUM, et al.ATP-citrate lyase links cellular metabolism to histone acetylation. Science2009; 324(5930): 1076–1080.
29.
HoutenSMWandersRJ. A general introduction to the biochemistry of mitochondrial fatty acid beta-oxidation. J Inherit Metab Dis2010; 33(5): 469–477.
30.
FosterPAMuellerJW. Sulfation Pathways: insights into steroid sulfation and desulfation pathways. J Mol Endocrinol2018; 61(2): T271–T283.
31.
OrayMAbu SamraKEbrahimiadibN, et al.Long-term side effects of glucocorticoids. Expert Opin Drug Saf2016; 15(4): 457–465.
32.
WuNYangMGaurU, et al.Alpha-ketoglutarate: physiological functions and applications. Biomol Ther (Seoul)2016; 24(1): 1–8.
33.
AsadiSAEdgarDLiaoCY, et al.Alpha-ketoglutarate, an endogenous metabolite, Extends lifespan and compresses morbidity in aging mice. Cell Metab2020; 32(3): 447–456.
34.
WangZLongHChangC, et al.Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview. Cell Mol Life Sci2018; 75(18): 3353–3369.
35.
MillsEO'NeillLA. Succinate: a metabolic signal in inflammation. Trends Cell Biol2014; 24(5): 313–320.
36.
RyanDGMurphyMPFrezzaC, et al.Coupling Krebs cycle metabolites to signalling in immunity and cancer. Nat Metab2019; 1: 16–33.
37.
Fernandez-VeledoSCeperuelo-MallafreVVendrellJ. Rethinking succinate: an unexpected hormone-like metabolite in energy homeostasis. Trends Endocrinol Metab2021; 32(9): 680–692.
38.
WuBWuYTangW. Heme catabolic pathway in inflammation and immune disorders. Front Pharmacol2019; 10: 825.
39.
HerradaAALlanosCMackern-ObertiJP, et al.Haem oxygenase 1 expression is altered in monocytes from patients with systemic lupus erythematosus. Immunology2012; 136(4): 414–424.
40.
XuTHolzapfelCDongX, et al.Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med2013; 11: 60.
41.
Rangel-HuertaODPastor-VillaescusaBGilA. Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies. Metabolomics2019; 15(6): 93.
42.
SadagopanNLiWRoberdsSL, et al.Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am J Hypertens2007; 20(11): 1209–1215.
43.
OkuKAtsumiT. Systemic lupus erythematosus: nothing stale her infinite variety. Mod Rheumatol2018; 28(5): 758–765.
44.
DeenPMRobbenJH. Succinate receptors in the kidney. J Am Soc Nephrol2011; 22(8): 1416–1422.
45.
KawataKLiuCYMerkelSF, et al.Blood biomarkers for brain injury: what are we measuring?Neurosci Biobehav Rev2016; 68: 460–473.
46.
SerenaCCeperuelo-MallafreVKeiranN, et al.Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. ISME J2018; 12(7): 1642–1657.
47.
BordagNKlieSJurchottK, et al.Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects. Sci Rep2015; 5: 15954.
48.
Elera-FitzcarraldCVegaKGamboa-CardenasRV, et al.Discrepant perception of lupus disease activity: a comparison between patients' and physicians' disease activity scores. J Clin Rheumatol2020; 26(7S Suppl 2): S165–S169.
49.
ArnaudLGavandPEVollR, et al.Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature. Rheumatology2019; 58(6): 987–996.
50.
FeltenRSagezFGavandPE, et al.10 most important contemporary challenges in the management of SLE. Lupus Sci Med2019; 6(1): e000303.
